TY - JOUR
T1 - Microbiota-Dependent Activation of an Autoreactive T Cell Receptor Provokes Autoimmunity in an Immunologically Privileged Site
AU - Horai, Reiko
AU - Zárate-Bladés, Carlos R.
AU - Dillenburg-Pilla, Patricia
AU - Chen, Jun
AU - Kielczewski, Jennifer L.
AU - Silver, Phyllis B.
AU - Jittayasothorn, Yingyos
AU - Chan, Chi Chao
AU - Yamane, Hidehiro
AU - Honda, Kenya
AU - Caspi, Rachel R.
N1 - Funding Information:
The authors thank Drs. Koji Atarashi (RIKEN) and Ivan Fuss (NIAID, NIH) for sharing protocols, Dr. Kristin Hogquist (University of Minnesota) for Nr4a1 GFP reporter mice, Dr. Gregory Liou (Medical College of Georgia) for Rbp3 −/− mice, all members of the R.R.C. lab for help and advice, NEI Flow Cytometry Core for assistance in cell sorting and analysis, NEI Genetic Engineering Core for the assistance in antibiotics treatment and mouse colony maintenance, NEI Histology Core for processing of histology specimens, and NIH-DVR Pathology and Bacteriology labs for bacteriological analysis. We thank Drs. Silvio Gutkind (NIDCR), William E. Paul (NIAID), Katsuko Sudo (Tokyo Medical University), and Kikuji Itoh (Japan SLC) for support and useful discussions. R.R.C. is supported by NEI intramural funding (project # EY000184 ) and K.H. is supported by CREST, Japan Science and Technology Agency (Tokyo, Japan) .
Publisher Copyright:
© 2015 Elsevier Inc.
PY - 2015/8/18
Y1 - 2015/8/18
N2 - Activated retina-specific T cells that have acquired the ability to break through the blood-retinal barrier are thought to be causally involved in autoimmune uveitis, a major cause of human blindness. It is unclear where these autoreactive T cells first become activated, given that their cognate antigens are sequestered within the immune-privileged eye. We demonstrate in a novel mouse model of spontaneous uveitis that activation of retina-specific T cells is dependent on gut commensal microbiota. Retina-specific T cell activation involved signaling through the autoreactive T cell receptor (TCR) in response to non-cognate antigen in the intestine and was independent of the endogenous retinal autoantigen. Our findings not only have implications for the etiology of human uveitis, but also raise the possibility that activation of autoreactive TCRs by commensal microbes might be a more common trigger of autoimmune diseases than is currently appreciated. It is unknown where and how T cells reactive to self antigens residing behind blood-tissue barriers first become activated. Caspi and colleagues show that retina-specific T cells receive an activation signal in the gut from a crossreactive antigen dependent on commensal microbiota and trigger autoimmunity in the eye.
AB - Activated retina-specific T cells that have acquired the ability to break through the blood-retinal barrier are thought to be causally involved in autoimmune uveitis, a major cause of human blindness. It is unclear where these autoreactive T cells first become activated, given that their cognate antigens are sequestered within the immune-privileged eye. We demonstrate in a novel mouse model of spontaneous uveitis that activation of retina-specific T cells is dependent on gut commensal microbiota. Retina-specific T cell activation involved signaling through the autoreactive T cell receptor (TCR) in response to non-cognate antigen in the intestine and was independent of the endogenous retinal autoantigen. Our findings not only have implications for the etiology of human uveitis, but also raise the possibility that activation of autoreactive TCRs by commensal microbes might be a more common trigger of autoimmune diseases than is currently appreciated. It is unknown where and how T cells reactive to self antigens residing behind blood-tissue barriers first become activated. Caspi and colleagues show that retina-specific T cells receive an activation signal in the gut from a crossreactive antigen dependent on commensal microbiota and trigger autoimmunity in the eye.
UR - http://www.scopus.com/inward/record.url?scp=84940930030&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940930030&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2015.07.014
DO - 10.1016/j.immuni.2015.07.014
M3 - Article
C2 - 26287682
AN - SCOPUS:84940930030
SN - 1074-7613
VL - 43
SP - 343
EP - 353
JO - Immunity
JF - Immunity
IS - 2
M1 - 3135
ER -